[go: up one dir, main page]

DE60006363D1 - Aminoacylaroylpyrrole für die behandlung des neuropathischen schmerzes - Google Patents

Aminoacylaroylpyrrole für die behandlung des neuropathischen schmerzes

Info

Publication number
DE60006363D1
DE60006363D1 DE60006363T DE60006363T DE60006363D1 DE 60006363 D1 DE60006363 D1 DE 60006363D1 DE 60006363 T DE60006363 T DE 60006363T DE 60006363 T DE60006363 T DE 60006363T DE 60006363 D1 DE60006363 D1 DE 60006363D1
Authority
DE
Germany
Prior art keywords
aminoacylaroylpyrrole
neuropathic pain
treating neuropathic
treating
pain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60006363T
Other languages
English (en)
Other versions
DE60006363T2 (de
Inventor
R Carson
M Pitis
E Rogers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceuticals Inc
Original Assignee
Ortho McNeil Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho McNeil Pharmaceutical Inc filed Critical Ortho McNeil Pharmaceutical Inc
Publication of DE60006363D1 publication Critical patent/DE60006363D1/de
Application granted granted Critical
Publication of DE60006363T2 publication Critical patent/DE60006363T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/333—Radicals substituted by oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/335—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
DE60006363T 1999-02-18 2000-02-17 Aminoacylaroylpyrrole für die behandlung des neuropathischen schmerzes Expired - Lifetime DE60006363T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12047799P 1999-02-18 1999-02-18
US120477P 1999-02-18
PCT/US2000/004063 WO2000048584A2 (en) 1999-02-18 2000-02-17 Aroyl aminoacyl pyrroles for use in the treatment of neuropathic pain

Publications (2)

Publication Number Publication Date
DE60006363D1 true DE60006363D1 (de) 2003-12-11
DE60006363T2 DE60006363T2 (de) 2005-07-21

Family

ID=22390558

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60006363T Expired - Lifetime DE60006363T2 (de) 1999-02-18 2000-02-17 Aminoacylaroylpyrrole für die behandlung des neuropathischen schmerzes

Country Status (14)

Country Link
US (2) US6191142B1 (de)
EP (1) EP1154996B1 (de)
JP (1) JP2002537247A (de)
AR (1) AR022620A1 (de)
AT (1) ATE253556T1 (de)
AU (1) AU3367500A (de)
CA (1) CA2361390A1 (de)
DE (1) DE60006363T2 (de)
DK (1) DK1154996T3 (de)
ES (1) ES2209843T3 (de)
HK (1) HK1041003B (de)
TR (1) TR200103219T2 (de)
TW (1) TW562797B (de)
WO (1) WO2000048584A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001271631A1 (en) 2000-06-30 2002-01-14 Ortho-Mcneil Pharmaceutical, Inc. Useful aroyl aminoacyl pyrrole compounds
EP1351950B1 (de) 2000-12-20 2007-08-08 Ortho-McNeil Pharmaceutical, Inc. Isochinolin-aroylpyrrole für die behandlung von krankheiten des zentralnervensystems
WO2003057219A1 (en) * 2001-12-27 2003-07-17 Ortho-Mcneil Pharmaceutical Inc. Aroyl pyrrole heteroeryl and methanols useful for treating a central nervous system disorder
JP4428053B2 (ja) 2002-02-05 2010-03-10 味の素株式会社 ガバペンチン若しくはプレガバリンおよびｎ型カルシウムチャンネル拮抗剤を含有する医薬組成物
HU230403B1 (hu) * 2003-12-19 2016-04-28 Pál Kocsis Nátrium csatorna blokkoló és szerotonin újrafelvétel gátló tartalmú gyógyszerkészítmény
EP2256103A1 (de) 2009-05-07 2010-12-01 Biosynth AG Neue Anzeigerplattform

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5332736A (en) * 1993-11-01 1994-07-26 Ortho Pharmaceutical Corporation Anti-convulsant aroyl aminoacylpyrroles
US5418236A (en) 1993-12-23 1995-05-23 Ortho Pharmaceutical Corporation Anxiolytic aroyl piperidinyl and piperazinylacyl pyrroles
WO1998007447A1 (en) 1996-08-23 1998-02-26 Algos Pharmaceutical Corporation Anticonvulsant containing composition for treating neuropathic pain
US5760007A (en) 1997-07-16 1998-06-02 Ortho Pharmaceutical Corporation Anticonvulsant derivatives useful in treating neuropathic pain

Also Published As

Publication number Publication date
DK1154996T3 (da) 2004-02-16
US6191142B1 (en) 2001-02-20
EP1154996A2 (de) 2001-11-21
TW562797B (en) 2003-11-21
DE60006363T2 (de) 2005-07-21
WO2000048584A3 (en) 2000-12-07
JP2002537247A (ja) 2002-11-05
TR200103219T2 (tr) 2002-04-22
HK1041003A1 (en) 2002-06-28
AR022620A1 (es) 2002-09-04
ES2209843T3 (es) 2004-07-01
HK1041003B (en) 2004-05-07
US20010044452A1 (en) 2001-11-22
CA2361390A1 (en) 2000-08-24
ATE253556T1 (de) 2003-11-15
EP1154996B1 (de) 2003-11-05
AU3367500A (en) 2000-09-04
WO2000048584A2 (en) 2000-08-24
US6369228B2 (en) 2002-04-09

Similar Documents

Publication Publication Date Title
EP0792137A4 (de) Pilzhemmende behandlung für die nägel
DE69927823D1 (de) Hydrogel für die therapeutische behandlung von aneurysmas
DE60024649D1 (de) Verbindungen für die behandlung von ischämie
DE69700723D1 (de) Behandlung für Formgedächtnislegierung
DE60130675D1 (de) Selektive agonisten des ep4 rezeptors für die behandlung von osteoporose
ZA200202449B (en) Use of retigabin for treating neuropathic pain.
DE60124576D1 (de) Verbindungen verwendbar für die behandlung von entzündungskrankheiten
ATE288431T1 (de) Substituierte bizyklische derivate für die behandlung von unnormalem zellwachstum
DE60218493D1 (de) Substituierte 7-aza-ä2.2.1übicycloheptane für die behandlung von krankheiten
DE60316538D1 (de) Dihydrobenzodiazepin-2-on-derivative für die behandlung von neurologischen erkrankungen
ATE498309T1 (de) Synergistische zusammensetzungen für die behandlung von saatgut
DE69912972D1 (de) Antibiotische zusammensetzungen zur behandlung des auges
DE60043868D1 (de) Abgeschwächte Mikroorganismen für die Behandlung von Infektionen
ATE502642T1 (de) Kombinationen für die behandlung von immun- entzündlichen erkrankungen
ATE263777T1 (de) Zusammensetzungen zur behandlung von entzündungsreaktionen
DE60231107D1 (de) Tetrahydro-pyrazinoä1,2-aüindole für die behandlung von krankheiten des zentralnervensystems
ATE276262T1 (de) Oxazinochinolone für die behandlung viraler infektionen
DE69913334T2 (de) Vorrichtung zur orthodontischen behandlung
DE60033020D1 (de) Gerät zur behandlung von zahnkaries
ATE493125T1 (de) Carbamatverbindungen zur behandlung von schmerz
DE69906856D1 (de) Methode für die Inhibition von Haarwuchs
DE69608864D1 (de) Mittel für die Wasserbehandlung
DE59801385D1 (de) Durchlaufanlage für die behandlung von werkstücken
DE60006363D1 (de) Aminoacylaroylpyrrole für die behandlung des neuropathischen schmerzes
ATE515266T1 (de) 2-(amino-3,4-dioxo-1-cyclobuten-1- yl)aminoalkylsäure-derivate für die schmerzbehandlung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: BOEHMERT & BOEHMERT, 28209 BREMEN